Carbidopa, Levodopa, and Entacapone
These highlights do not include all the information needed to use CARBIDOPA, LEVODOPA AND ENTACAPONE safely and effectively. See full prescribing information for CARBIDOPA, LEVODOPA AND ENTACAPONE. CARBIDOPA, LEVODOPA AND ENTACAPONE tablets, for oral useInitial U.S. Approval: 2003
9c16c0e0-3b97-486b-b7d5-579f5853e2c5
HUMAN PRESCRIPTION DRUG LABEL
Feb 1, 2016
Sandoz Inc
DUNS: 005387188
Products 6
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Carbidopa, Levodopa, and Entacapone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
Carbidopa, Levodopa, and Entacapone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
Carbidopa, Levodopa, and Entacapone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
Carbidopa, Levodopa, and Entacapone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
Carbidopa, Levodopa, and Entacapone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
Carbidopa, Levodopa, and Entacapone
Product Details
FDA regulatory identification and product classification information